OOIR: Observatory of International Research

Papers

(The TQCC of Clinical and Translational Allergy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
	144
	46
Allergic patients during the COVID‐19 pandemic—Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey	45
Real‐life data on inactivated COVID‐19 vaccination in patients with subcutaneous allergen immunotherapy	38
Epicutaneous immunotherapy for food allergy: A systematic review and meta‐analysis	37
Correction to “Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety”	36
Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps	34
Self‐reported accidental allergic reactions among patients with challenge‐verified food allergy	33
Direct and indirect costs of allergic and non‐allergic rhinitis to adults in Beijing, China	31
Sensitivity to change and minimal clinically important difference of the angioedema control test	31
Evaluation of Diagnosis, Cross‐Reactivity, and Risk Factors in Pediatric Patients With Macrolide Allergy	28
Large‐scale plasma proteomics can reveal distinct endotypes in chronic obstructive pulmonary disease and severe asthma	28
Eczema in early childhood increases the risk of allergic multimorbidity	25
Lung Acetate Levels Decline in Correlation With Increased Type 2 Allergic Markers in a House Dust Mite Allergic Mouse Model	25
Application of a dried blood spot based proteomic and genetic assay for diagnosing hereditary angioedema	23
	23
Physical Exercise Improves Symptomatic Dermographism	22
Effects of anti‐IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real‐life multicentre study (BIONIGE)	21
MASK‐air^® real‐world data in respiratory allergy in old‐age adults	21
The holo beta‐lactoglobulin lozenge reduces symptoms in cat allergy—Evaluation in an allergen exposure chamber and by titrated nasal allergen challenge	20
Understanding and controlling asthma in Latin America: A review of recent research informed by the SCAALA programme	19
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project	19
Issue Information	18
Efficacy of probiotics in pediatric atopic dermatitis: A systematic review and meta‐analysis	18
Omalizumab for successful chemotherapy desensitisation: What we know so far	18

Issue Information	18
Predicting Blomia tropicalis allergens using a multiomics approach	18
Issue Information	17
Relationship between longitudinal changes in type‐2 inflammation, immunoglobulin E sensitization, and clinical outcomes in young asthmatics	17
Proof‐of‐concept study of anti‐Fel d 1 IgY antibodies in cat food using the MASK‐air^® app	17
	17
Genetic variants in Hippo pathway genes are associated with house dust mite‐induced allergic rhinitis in a Chinese population	17
Issue Information	16
Benralizumab and the integrated management of co‐morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps	16
Corrigendum: Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study	16
Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety	16
Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response	15
Charcot‐Leyden crystals in tissues	15
	15
Anaphylaxis management in a French pediatric emergency department: Lessons from the ANA‐PED study	15
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK‐air study	15
Characterization of Chronic Rhinosinusitis Patients Based on Markers of Type 2 Inflammation: Findings From the European CRS Outcome Registry (CHRINOSOR)	14
Asthma is associated with increased severity and duration of rhinitis: A study with the Allergic Rhinitis and its Impact on Asthma classes in the Constances cohort	14
Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis	14
	14
Why the role of mHealth in allergy diagnosis and treatment adherence cannot be overlooked	14
Contact allergens in moisturizers in preventative emollient therapy – A systematic review	14
Effect of air filtration on house dust mite, cat and dog allergens and particulate matter in homes	14
	14
Breath of relief: Transforming pediatric asthma care with telemedicine‐guided exercises	14
Ethnic differences in depression and anxiety among adults with atopic eczema: Population‐based matched cohort studies within UK primary care	14
Issue Information	13
Type 2 gene expression signature in severe asthma associates with more advanced airway remodeling	13
DNA methylation profile in patients with indolent systemic mastocytosis	13
Effectiveness of mobile health interventions to improve nasal corticosteroid adherence in allergic rhinitis: A systematic review	13
Characteristics of mucin hypersecretion in different inflammatory patterns based on endotypes of chronic rhinosinusitis	13
A robust mRNA signature obtained via recursive ensemble feature selection predicts the responsiveness of omalizumab in moderate‐to‐severe asthma	13
Food allergy: What are people looking for? An infodemiology study	13
Comparative metabolomics analysis of bronchial epithelium during barrier establishment after allergen exposure	12
Immunoregulatory effects of Lactococcus lactis‐derived extracellular vesicles in allergic asthma	12
Upsides and downsides of a telecounselling model of integrated asthma management between general practitioners and specialists	12
Association between telomere length and atopic dermatitis among school‐age children	12
	12
Issue Information	12
Natural pollen exposure increases in a dose‐dependent way Fraction of exhaled Nitric Oxide (FeNO) levels in patients sensitized to one or more pollen species	12
Adverse events for biologics in patients with CRSwNP: A meta‐analysis	12
	11
Aerobiology matters: Why people in the community access pollen information and how they use it	11
Suppressed pediatric asthma hospitalizations during the COVID‐19 pandemic in Japan, from a national survey	11
Issue Information	10
T cell immunophenotypes and IgE responses in patients with moderate‐to‐severe atopic dermatitis receiving dupilumab	10
Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey	10
Dietary fibre in relation to asthma, allergic rhinitis and sensitization from childhood up to adulthood	10
	10
Role of impulse oscillometry in chronic obstructive pulmonary disease and asthma‐chronic obstructive pulmonary disease overlap	10

	10
Inflammatory related plasma proteins involved in acute preschool wheeze	10
Risk assessment behaviour when eating out in adults with food hypersensitivity	10
Effect of infant viral respiratory disease on childhood asthma in a non‐industrialized setting	10
Fractional exhaled nitric oxide levels in relation to work‐related respiratory burden and sensitization to wheat flour and multigrain in bakers	10
Effectiveness of Ectoin lozenges on oropharyngeal allergic symptoms	9
Socioeconomic status and different forms of rhinitis in Swedish adults	9
IgE and high‐affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance	9
The impact of COVID‐19 on hay fever treatment in Japan: A retrospective cohort study based on the Japanese claims database	9
Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity	9
Real‐world drug use in asthma, chronic obstructive pulmonary disease, rhinitis, cough, and cold in Finland from 1990 to 2021: Association with reduced disease burden	9
Issue Information	9
Advent of oral medications for the treatment of hereditary angioedema	9
Issue Information	9
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model	9
	8
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities	8
The efficacy and safety of oral microecological agents as add‐on therapy for atopic dermatitis: A systematic review and meta‐analysis of randomized clinical trials	8
Prevalence of sensitization to molecular food allergens in Europe: A systematic review	8
Issue Information	8
Gut microbial alteration in chronic spontaneous urticaria unresponsive to second generation antihistamines and its correlation with disease characteristics‐ a cross‐sectional case‐control study	8
Normalisation of airflow limitation in asthma: Post‐hoc analyses of TRIMARAN and TRIGGER	8
INMUNOCAT study: The impact of molecular diagnosis on immunotherapy prescription in pollen polysensitized patients from Catalonia	8
Work‐related dysphonia in subjects with occupational asthma is associated with neutrophilic airway inflammation	8
Issue Information	8
Issue Information	8
Issue Information	8
Omalizumab prevents respiratory illnesses in non‐atopic chronic spontaneous urticaria patients: A prospective, parallel‐group, pilot pragmatic trial	7
Dupilumab improves clinical and histologic features of eosinophilic esophagitis prior to 12 weeks of treatment	7
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air^®approach	7
High‐risks drug adverse events associated with Cetirizine and Loratadine for the treatment of allergic diseases: A retrospective pharmacovigilance study based on the FDA adverse event reporting system	7
The present and future of digital health, digital medicine, and digital therapeutics for allergic diseases	7
Association of bronchial steroid inducible methylation quantitative trait loci with asthma and chronic obstructive pulmonary disease treatment response	7
Issue Information	7
Issue Information	7
Associations with food allergy‐related psychological distress in a global sample of adults, children and caregivers	7
Prevalence, predictors, and clinical relevance of α‐gal sensitization in patients with chronic urticaria	7
Clinical review: The suggested management pathway for urticaria in primary care	7
Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat	7
Atopic Dermatitis Activity Score 7 (ADAS7): A tool for disease activity assessment	7
Lack of detection of aluminium‐reactive T‐lymphocytes in patients with SCIT‐induced granulomas	7
Is there a role of genetics in acute and chronic urticaria—A systematic review and meta‐analysis	7
	7
Comparison of skin prick test and prick‐to‐prick test with fruits and vegetables in the diagnosis of food allergy	6
Peanut allergen Ara h 6 is detectable in blood transfusion products	6
Correction to HLA‐A24:02 increase the risk of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms (DRESS) in HLA‐B58:01 carriers in Korean population; A multicenter cross‐secti	6
Issue Information	6
Exercise‐induced eosinophil responses: Normal cell counts with a marked decrease in responsiveness	6
Development of childhood asthma prediction models using machine learning approaches	6
Implementation of Rapid Drug Desensitization in Antineoplastic Drug Therapy in Denmark Using One‐Bag Protocols	6
Predictive significance of Charcot‐Leyden crystal structures for nasal polyp recurrence	6
Risk factors of NSAID‐exacerbated respiratory disease: A population‐based study	6
10 practical priorities to prevent and manage serious allergic reactions: GA²LEN ANACare and EFA Anaphylaxis Manifesto	6
Identification of potential drug targets for allergic diseases from a genetic perspective: A mendelian randomization study	6
Aeroallergen sensitivity patterns in Gulf countries: A systematic review	6
The expression of MUC5AC in patients with rhinosinusitis: A systematic review and meta‐analysis	6
Novel, computational IgE‐clustering in a population‐based cross‐sectional study: Mapping the allergy burden	6
Comparative study of novel dosing schedules for interrupted immunotherapy for allergic rhinitis	6
Interleukin‐33 increases type 2 innate lymphoid cell count and their activation in eosinophilic asthma	6